October-December 2022 - Volume 7 - Issue 4 - Contributor Index

Alphabetical Search
E
I
K
O
Q
U
V
Author:
A, Geru

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Chang, Shufu

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Chu, Xi

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Deruiter, Jack

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Feng, Bo

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Fu, Mingqiang
Author:
Ge, Junbo

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Guo, Lixin

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Guo, Wei
Author:
Han, Wenzheng
Author:
Huo, Yong

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Ji, Linong

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Jia, Qian

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Jiang, Song

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Jin, Zhengyang
Author:
Li, Jing
Author:
Li, Linjie
Author:
Li, Yong

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Li, Yongle
Author:
Liu, Fang

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Liu, Feng
Author:
Liu, Qing
Author:
Liu, Xinfeng

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Liu, Yuping

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Lowery, Payton

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Lu, Bin

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Lv, Ankang

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Ma, Jianying
Author:
Moore, Timothy

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Nadar, Rishi M.

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Pathak, Suhrud

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Pei, Haifeng
Author:
Ramesh, Sindhu

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Ren, Jun

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Smith, Forrest

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Steinke, Ian

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Su, Xi
Author:
Sun, Pengfei

Cardiovascular toxin-induced hyperglycemic and hypoarousal pathology-associated cognitive impairment: an in silico and in vivo validation

Sundari, S. Karpagam Kumara; Alturki, Mansour; Steinke, Ian; More

Cardiology Plus. 7(4):178-185, October-December 2022.

Author:
Tian, Jing
Author:
Wang, Jiabin
Author:
Wang, Ming
Author:
Wang, Peng
Author:
Wang, Xiong
Author:
Wang, Yongjun

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Wang, Zhuoqun
Author:
Weng, Jianping

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Xu, Chengyi
Author:
Yang, Haixia
Author:
Yang, Qing
Author:
Ye, Xianglin
Author:
Yin, Jianhan
Author:
Yuan, Pengfei
Author:
Zeng, Qiang

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Zhang, Shuyi
Author:
Zhang, Yingmei

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Zhou, Jingmin

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

Chu, Xi; Feng, Bo; Ge, Junbo; More

Cardiology Plus. 7(4):162-177, October-December 2022.

Author:
Zhou, Xin
Show: